" /> Olutasidenib - CISMeF





Preferred Label : Olutasidenib;

NCIt synonyms : IDH1-R132 Inhibitor FT-2102; 2-Pyridinecarbonitrile, 5-(((1S)-1-(6-chloro-1,2-dihydro-2-oxo-3-quinolinyl)ethyl)amino)-1,6-dihydro-1-methyl-6-oxo-;

NCIt definition : An orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1; IDH-1; IDH1 [NADP ] soluble) with a mutation at arginine (R) 132, IDH1(R132), with potential antineoplastic activity. Upon administration, olutasidenib specifically inhibits IDH1(R132), thereby inhibiting the formation of the oncometabolite 2-hydroxyglutarate (2HG) from alpha-ketoglutarate (a-KG). This prevents 2HG-mediated signaling and leads to both an induction of cellular differentiation and an inhibition of cellular proliferation in tumor cells expressing IDH(R132). IDH1(R132) mutations are highly expressed in certain malignancies, including gliomas; they initiate and drive cancer growth by both blocking cell differentiation and catalyzing the formation of 2HG.;

UNII : 0T4IMT8S5Z;

InChIKey : NEQYWYXGTJDAKR-JTQLQIEISA-N;

CAS number : 1887014-12-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1887014-12-1 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Rezlidhia;

Molecule name : FT 2102; FT-2102;

NCI Metathesaurus CUI : CL507891;

Codes from synonyms : 111358;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
09/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.